These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36560591)

  • 21. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
    Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
    Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.
    Dhanesh VV; Hosamani M; Basagoudanavar SH; Saravanan P; Biswal JK; Tamil Selvan RP; Madhavan A; Sehrish K; Sanyal A; Sreenivasa BP
    Appl Microbiol Biotechnol; 2020 Mar; 104(6):2589-2602. PubMed ID: 32002597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
    Cubillos C; de la Torre BG; Bárcena J; Andreu D; Sobrino F; Blanco E
    Virol J; 2012 Mar; 9():66. PubMed ID: 22416886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A.
    Kim DW; Cho G; Kim H; Lee G; Lim TG; Kwak HY; Park JH; Park SH
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of immunogenicity and cross-reactive responses of  vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle.
    Li P; Huang S; Zha J; Sun P; Li D; Bao H; Cao Y; Bai X; Fu Y; Ma X; Li K; Yuan H; Zhang J; Zhao Z; Wang J; Zhang K; Chen Y; Zhang Q; Qi S; Liu Z; Lu Z
    Vet Res; 2022 Jul; 53(1):56. PubMed ID: 35804412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine.
    Al Amin M; Ali MR; Islam MR; Alam ASMRU; Shill DK; Rahman MS; Siddique MA; Sultana M; Hossain MA
    Vaccine; 2020 Jul; 38(32):4970-4978. PubMed ID: 32535015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interference effect of maternally-derived antibodies on the serological performance of pigs immunized with a foot-and-mouth disease oil emulsion vaccine.
    Kim J; Kim T; Hong JK; Lee HS; Lee KN; Jo HJ; Choi J; Choi J; Lee SH; Lee MH; Kim B; Park JH
    Vaccine; 2020 Feb; 38(7):1723-1729. PubMed ID: 31892447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
    Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
    Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.
    Liu W; Shao J; Zhang G; Chang Y; Ge S; Sun Y; Gao Z; Chang H
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33328177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity Evaluation of an Experimental Designed Nanoliposomal Vaccine Containing FMDV Immunodominant Peptides.
    Heshmati L; Rezayat SM; Madani R; Emami T; Jafari MR; Golchinfar F; Kazemi M; Azimi Dezfouli SM
    Arch Razi Inst; 2021 Nov; 76(5):1183-1190. PubMed ID: 35355777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.